SD
Therapeutic Areas
Propanc Biopharma Pipeline
| Drug | Indication | Phase |
|---|---|---|
| PRP | Advanced Solid Tumors (Pancreatic, Ovarian) | Phase 1/2 |
Leadership Team at Propanc Biopharma
JN
James Nathanielsz
Chief Executive Officer, Managing Director
DJ
Dr. Julian Kenyon
Former Chief Scientific Officer
DK
Dr. Klaus Kutz
Former Chief Medical Officer
BB
Belinda Bales
Former Company Secretary
RS
Roland Scollay
Former Board Member
PC
Paul C. H. Lee
Former Board Member